Cowen And Company, LLC Abb Vie Inc. Transaction History

Cowen And Company, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $276,802 - $324,874	3,222 New	3,222 $282,000
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $1.46 Million - $1.96 Million	-19,960 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $1.29 Million - $1.95 Million	19,960 New	19,960 $1.52 Million

3,693

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.